openPR Logo
Press release

Parainfluenza Virus Infection Therapeutics Market Size in the 7MM was ~USD 259 Million in 2023, is estimated to increase by 2034 and estimated DelveInsight

01-09-2025 12:22 AM CET | Health & Medicine

Press release from: ABNewswire

Parainfluenza Virus Infection Therapeutics Market Size in

DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology and the Parainfluenza Virus Infection market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Unlock key insights into the Parainfluenza Virus Infection Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Parainfluenza Virus Infection Market Size [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Parainfluenza Virus Infection Market Report

* In November 2024:- Ansun Biopharma Inc.:- All eligible subjects in the PoI with a respiratory infection due to any SAD-RV infection except PIV. Eligible subjects with both PIV and an additional concurrent SAD-RV, will be enrolled for either Cohorts 2 or 3 depending on their age. There is no lower age limit for this cohort.
* According to DelveInsight estimations, 2,709,923 Cases of Parainfluenza virus infection were found in 2023 in the 7MM.
* As per DelveInsight's estimations, the total number of incident cases of parainfluenza virus in the United States were 1,456,399 in 2023 and are projected to increase during the forecast period.
* According to DelveInsight's estimates, the total Incident Cases of parainfluenza virus infection in EU4 and the UK were found to be 991,115 in 2023. The highest proportion of parainfluenza virus infection cases was reported in Spain among the EU4 countries, while the least number of cases was found in the UK.
* The estimates show the number of parainfluenza virus infection cases in Japan was found to be approximately 262,409 in 2023, which is estimated to increase by 2034.
* The leading Parainfluenza Virus Infection Companies such as Ansun Biopharma, AlloVir , and others.
* Promising Parainfluenza Virus Infection Therapies such as DAS181, MEDI-534 , and others.

Stay ahead in the competitive landscape of the Parainfluenza Virus Infection Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Parainfluenza Virus Infection Treatment Market Size [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=yprhttps://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Parainfluenza Virus Infection Epidemiology Segmentation in the 7MM

* Total Parainfluenza Virus Infection Incident Cases
* Parainfluenza Virus Infection Serotype-Specific Incident Cases
* Parainfluenza Virus Infection Gender-specific Incident Cases
* Parainfluenza Virus Infection Age-specific Incident Cases

Download the report to understand which factors are driving Parainfluenza Virus Infection epidemiology trends @ Parainfluenza Virus Infection Prevalence [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Parainfluenza Virus Infection Emerging Drugs

* DAS181: Ansun Biopharma

DAS181 is a first-in-class recombinant sialidase protein that is designed to remove sialic acids located on the surface of epithelial cells lining the human respiratory tract. These sialic acids are naturally present on cell surfaces and are needed by some viruses for viral entry into cells. Cleavage of sialic acid inactivates the mechanism for viral entry and infection, interrupting the virus lifecycle and giving patients the chance to recover. DAS181 has demonstrated antiviral activity against three of the four major respiratory viruses, influenza virus (IFV), parainfluenza virus (PIV), and metapneumovirus (MPV), as well as human enterovirus-68 (EV-68).

* ALVR106: AlloVir

ALVR106 is an allogeneic, off-the-shelf, multivirus-specific VST investigational therapy designed to target infections and diseases caused by the respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). In vitro data demonstrate that ALVR106 has antiviral activity against each of the targeted viruses with minimal or no activity against non-virus-infected cells. (AlloVir, 2024).

Parainfluenza Virus Infection Market Outlook

Presently, the primary approach to treating HPIV infection involves supportive care, except for croup, where corticosteroids have been identified as beneficial. Novel drugs like DAS181 show promise for treating severe cases in immunocompromised patients and are currently undergoing development. Despite continuous endeavors, effective treatment options for PIV infection remain lacking, with no approved medications addressing this critical gap in care. Specifically, there is still no FDA-approved cure or antiviral medication designated for treating HPIV infection.

Discover the future of Parainfluenza Virus Infection treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ Parainfluenza Virus Infection Market Drivers and Barriers [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Parainfluenza Virus Infection Companies

Ansun Biopharma, AlloVir, and others.

Parainfluenza Virus Infection Treatment Market

The Parainfluenza Virus Infection Treatment Market addresses the growing demand for therapies that manage and mitigate infections caused by the human parainfluenza viruses (HPIVs). These viruses are a leading cause of respiratory illnesses, particularly in young children, the elderly, and immunocompromised individuals. While HPIVs can cause mild cold-like symptoms in some, they are known to lead to more severe conditions such as croup, bronchiolitis, and pneumonia.

Explore the dynamics of the Parainfluenza Virus Infection Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Parainfluenza Virus Infection Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Scope of the Parainfluenza Virus Infection Market Report

* Coverage- 7MM
* Study Period- 2020-2034
* Parainfluenza Virus Infection Companies- Ansun Biopharma, AlloVir , and others.
* Parainfluenza Virus Infection Therapies such as DAS181, MEDI-534 , and others.
* Parainfluenza Virus Infection Therapeutic Assessment: Parainfluenza Virus Infection marketed and Parainfluenza Virus Infection emerging therapies
* Parainfluenza Virus Infection Market Dynamics: Parainfluenza Virus Infection market drivers and Parainfluenza Virus Infection market barriers
* Parainfluenza Virus Infection Unmet Needs, KOL's views, Analyst's views, Parainfluenza Virus Infection Market Access and Reimbursement

Table of Content

1. Key Insights

2. Report Introduction

3. Parainfluenza Virus Infection Market Overview by Therapies

4. Epidemiology and Market Methodology of PIV Infection

5. Executive Summary of PIV Infection

6. Key Events

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Emerging Therapies

11. Parainfluenza Virus Infection: The Seven Major Market Analysis

12. Key Opinion Leaders' Views

13. SWOT Analysis

14. Unmet Needs

15. Market Access and Reimbursement

16. Appendix

17. Report Methodology

18. DelveInsight Capabilities

19. Disclaimer

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=parainfluenza-virus-infection-therapeutics-market-size-in-the-7mm-was-usd-259-million-in-2023-is-estimated-to-increase-by-2034-and-estimated-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-infections-market



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parainfluenza Virus Infection Therapeutics Market Size in the 7MM was ~USD 259 Million in 2023, is estimated to increase by 2034 and estimated DelveInsight here

News-ID: 3808294 • Views:

More Releases from ABNewswire

Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repair Services to Support St. Louis Park Homeowners
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold. Responding to a Growing Need for Water Damage Restoration Property owners across Minnesota are increasingly seeking
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Injury Attorneys Representation in Port Jefferson Station
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents. Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washing Prevents Long-Term Damage in Millsboro DE
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces. In
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection. Market Overview: Understanding Tampa Bay Remodeling Investment Trends Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.

All 5 Releases


More Releases for Infection

Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Infection Prevention Market? In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market? The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization. The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The yeast infection
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications. The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026. The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,